Image of Stella Sun

Stella Sun

Associate

Email

stella.sun@aoshearman.com

Phone

+1 646 434 9238

Offices

New York

V-CARD
Stella advises companies on their public disclosures, corporate governance and securities law matters.

Representative companies include Ardagh Group, Bunge, CVS Health and Quest Diagnostics.

She also represents companies and investment banks in a wide variety of public and private capital raising and liability management transactions, including IPOs, investment-grade and high-yield debt offerings, at-the-market offerings, PIPEs, tender offers and consent solicitations.

Expertise

Industries

Experience

Representative matters

  • The underwriters on the IPO and Nasdaq listing of CeriBell, Inc., a commercial-stage medical technology company with a novel point-of-care EEG platform using AI-powered seizure detection algorithms.
  • The underwriters on the IPO and Nasdaq listing of Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
  • The underwriters on the IPO and NYSE listing of Paragon 28, Inc., a medical device company focused on the foot and ankle orthopedic market.
  • Quest Diagnostics Incorporated on its $1.85 billion senior notes offerings.
  • CVS Health Corporation on its acquisition of Oak Street Health, Inc. and the related $5 billion notes offering.

Qualifications

Admissions

New York

Academic

New York University School of Law, J.D.

Nankai University, Bachelor of Economics

Languages

Mandarin
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.